PRODUCT INFORMATION
Description
iRGD peptide (Cys-Arg-Gly-Asp-Lys-Gly-Pro-Asp-Cys) is the archetypal tumor-penetrating peptide. It targets αv integrins and is subsequently cleaved to expose a C-end Rule (CendR) motif, which binds to neuropilin-1 to enhance tissue penetration. It is used in research models to improve the distribution of co-administered agents and exhibits inherent anti-migratory activities in vitro.
Molecular Weight
1064.08
Purity
> 95%
Formula
C₃₇H₆₀F₃N₁₃O₁₆S₂
Product Type
Targeting Peptide
Sequence
Cys-Arg-Gly-Asp-Lys-Gly-Pro-Asp-Cys
Form (20 deg.C)
Solid
Storage Condition
Store sealed at -20°C, away from moisture.
For Research Use Only | Not For Clinical Use
Related products
- Tumor Targeted Pro-apoptotic Peptide (CAT#: OLY-1025-YS-48)
- Cyclo(Arg-Ala-Asp-(D-Tyr)-Lys) Targeting Peptide (CAT#: OLY-1025-YS-36)
- NBD-LLLLpY Targeting Peptide (CAT#: OLY-1025-YS-50)
- Thrombospondin-1 (1016-1021) (human, Bovine, Mouse) Targeting Peptide (CAT#: OLY-1025-YS-45)
- Octreotide Targeting Peptide (CAT#: OLY-1025-YS-3)
- Tyr-Somatostatin-14 Targeting Peptide (CAT#: OLY-1025-YS-63)
- REA Targeting Peptide (CAT#: OLY-1025-YS-66)
- 293P-1 Targeting Peptide (CAT#: OLY-1025-YS-17)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.